SCHEMBL19249192

SCHEMBL19249192

CC(C)c1ccc(O)c(F)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 6/20 0.50
▸ GABRB2 P47870 4/20 0.50
▸ GABRB1 P18505 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ SLC6A2 P23975 2/20 0.50
▸ HTR2B P41595 2/20 0.50
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ FAAH O00519 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ GABRG2 P18507 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ HTR2C P28335 1/20 0.50
▸ GABRB3 P28472 1/20 0.50
▸ GABRA5 P31644 1/20 0.50
▸ GABRA3 P34903 1/20 0.50
▸ GABRA2 P47869 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20443883 0.84 ADRA1A (0.45) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL2737293 0.82 GABRA1 (0.50) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL15631302 0.82 ADRA1A (0.57) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL2738307 0.80 GABRA1 (0.48) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL27691694 0.79 ADRB2 (0.39) PTGS1ADRA1AADRB2ADRB1ADRB3
SCHEMBL487169 0.78 GABRA1 (0.56) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL27691695 0.78 ADRB2 (0.38) ADRA1AADRB2ADRB1ADRB3ADRA2A
SCHEMBL29699645 0.77 GABRA1 (0.68) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL2585105 0.77 GABRA1 (0.68) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL25221643 0.76 GABRA1 (0.54) GABRA1GABRB2GABRB1LMNASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914719-B2 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 ASTEX THERAPEUTICS LTD. (GB) 2018-03-13 — — US disclosed
US-9730912-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2017-08-15 — — US disclosed
Send feedback